GlassScriptPhysician profile
Robert N Honea
NPI 1083713556
$7,088.29
in general payments reported to CMS, 2019-2025
44 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $860 · 2021: $1,171 · 2022: $1,002 · 2023: $1,106 · 2024: $913 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,114.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $928.24 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $730.12 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $639.76 | 2019-2023 | Xarelto |
| Amgen INC. | $553.36 | 2019-2024 | Otezla, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $462.63 | 2019-2025 | Rexulti, Abilify Asimtufii |
| Novo Nordisk INC | $422.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $315.88 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $264.60 | 2022-2025 | |
| Daiichi Sankyo INC. | $252.76 | 2019-2023 | Injectafer |
| Pfizer INC. | $245.96 | 2019-2025 | |
| Eisai INC. | $219.87 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $181.18 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $175.43 | 2023-2025 | Caplyta |
| Glaxosmithkline, LLC. | $159.28 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.11 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Honea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.